AdaptHealth (NASDAQ:AHCO) Given New $13.00 Price Target at Canaccord Genuity Group

AdaptHealth (NASDAQ:AHCO) had its price target reduced by Canaccord Genuity Group from $14.00 to $13.00 in a report issued on Wednesday,Benzinga reports. They currently have a buy rating on the stock.

Other analysts have also recently issued research reports about the company. Robert W. Baird decreased their target price on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a report on Wednesday. Royal Bank of Canada reiterated an “outperform” rating and set a $13.00 target price on shares of AdaptHealth in a report on Monday, August 12th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.17.

AdaptHealth Stock Up 2.6 %

AHCO opened at $10.09 on Wednesday. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 0.94. The stock has a market capitalization of $1.36 billion, a price-to-earnings ratio of -6.12, a price-to-earnings-growth ratio of 1.58 and a beta of 1.11. The business has a 50-day moving average of $10.70 and a two-hundred day moving average of $10.44. AdaptHealth has a 12 month low of $6.43 and a 12 month high of $11.90.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.02). AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. The business had revenue of $805.90 million during the quarter, compared to analysts’ expectations of $809.32 million. During the same quarter last year, the firm earned $0.19 EPS. The firm’s quarterly revenue was up .2% compared to the same quarter last year. On average, research analysts expect that AdaptHealth will post 0.87 earnings per share for the current year.

Insider Buying and Selling

In related news, COO Shaw Rietkerk sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $11.24, for a total transaction of $281,000.00. Following the transaction, the chief operating officer now directly owns 212,611 shares of the company’s stock, valued at approximately $2,389,747.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, COO Shaw Rietkerk sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $11.24, for a total transaction of $281,000.00. Following the transaction, the chief operating officer now directly owns 212,611 shares of the company’s stock, valued at approximately $2,389,747.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director David Solomon Williams III sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total value of $45,040.00. Following the completion of the transaction, the director now directly owns 36,899 shares in the company, valued at approximately $415,482.74. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.43% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On AdaptHealth

A number of institutional investors have recently made changes to their positions in AHCO. Janney Montgomery Scott LLC raised its position in shares of AdaptHealth by 80.1% in the 1st quarter. Janney Montgomery Scott LLC now owns 27,949 shares of the company’s stock valued at $322,000 after purchasing an additional 12,430 shares in the last quarter. Texas Permanent School Fund Corp raised its position in shares of AdaptHealth by 1.4% in the 1st quarter. Texas Permanent School Fund Corp now owns 71,201 shares of the company’s stock valued at $820,000 after purchasing an additional 979 shares in the last quarter. Empowered Funds LLC raised its position in shares of AdaptHealth by 8.2% in the 1st quarter. Empowered Funds LLC now owns 502,762 shares of the company’s stock valued at $5,787,000 after purchasing an additional 38,084 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of AdaptHealth during the 1st quarter valued at approximately $129,000. Finally, Sei Investments Co. acquired a new stake in shares of AdaptHealth during the 1st quarter valued at approximately $2,365,000. 82.67% of the stock is owned by institutional investors and hedge funds.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.